Business Context and Reporting Period
This Form 8-K is a current report filed by Marathon Patent Group, Inc. (not MARA Holdings, Inc.) on September 19, 2014, covering events occurring on September 16 and 17, 2014. The filing details the entry into a material consulting agreement, the adoption of new equity and director compensation plans, and the results of the annual shareholder meeting held on September 16, 2014.
Key Financial Metrics and Agreements
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or debt levels. Instead, it outlines specific financial commitments and equity issuances:
- Consulting Agreement: The Company entered into an agreement with GRQ Consultants, Inc., granting 100,000 shares of preferred stock (50% vested immediately, 50% vesting over six months) plus potential performance-based shares.
- 2014 Equity Incentive Plan: Authorized the issuance of up to 1,500,000 shares of common stock for directors, officers, consultants, and employees.
- Director Compensation: Established annual cash retainers of $36,000 for non-employee directors, with additional fees for committee service ranging from $2,500 to $10,000. Directors may elect to receive compensation in restricted stock or options.
- Option Grant Pricing: Option awards granted to directors have an exercise price of $14.89 per share, based on the closing price on September 15, 2014.
Material Changes and Corporate Actions
The following material changes and actions were reported:
- Equity Plan Adoption: The Board adopted the 2014 Equity Incentive Plan and the Non-Employee Director Compensation Plan, subject to shareholder approval by September 16, 2015.
- Shareholder Meeting Results:
- All five director nominees (John Stetson, Edward Kovalik, Stuart Smith, William Rosellini, Doug Croxall) were re-elected.
- Shareholders approved the 2013 executive compensation (Say-on-Pay) with 2,281,689 votes for and 48,290 against.
- Shareholders voted to conduct future Say-on-Pay votes every three years (1,427,282 votes for).
- Shareholders ratified the appointment of SingerLewak LLP as independent auditors for the fiscal year ending December 31, 2014.
Guidance, Risks, and Contingencies
The filing contains no forward-looking financial guidance or management commentary regarding future business outlook. Key contingencies and risks identified include:
- Shareholder Approval Condition: The issuance of preferred stock to GRQ Consultants and any grants to non-employee directors under the 2014 Plan are contingent upon shareholder approval of the 2014 Plan on or prior to September 16, 2015. If approval is not obtained, these grants will be cancelled.
- Conversion Restrictions: Preferred stock issued to the consultant cannot be converted into common stock due to equity blockers designed to comply with NASDAQ Listing Rule 5635(d).
- Valuation: The Board is authorized to retain a third-party valuation expert to value restricted stock awards for directors.
Investor Verification Checklist
- Verify the status of the shareholder vote required by September 16, 2015, to confirm if the 100,000 preferred shares to GRQ and director equity grants will be issued.
- Review the full text of the Consulting Agreement (Exhibit 10.1) to understand specific performance benchmarks for additional share issuance.
- Confirm the total number of shares outstanding post-issuance to assess potential dilution from the 1,500,000 share pool authorized in the 2014 Plan.
- Check subsequent filings to ensure SingerLewak LLP continued as the independent auditor for the 2014 fiscal year.